AN OVERVIEW OF CHINESE DRUG REGULATORY SYSTEM: A REVIEW
Abstract
The Drug regulatory authority of China was renewed from state pharmaceutical administration of China (SPAC) to state food and Drug administration (SFDA) with the announcement and declaration of Chinese ministry of health, the established regulatory standards of SFDA were keen to keep with international standards of EU, Japan and USA, the Drug registrations and Drug approvals are carried with established affiliated units for fast track evaluation within prescribed period ordered by SFDA, the state food and Drug administration is developed stringently and modified its standards according to the US healthcare regulatory system, in this review the permanently keeping standards of regulatory functions were detailed, and the untiring responsibilities of affiliated units of SFDA were to be recognized where their performance was a key aspect.
Downloads
References
http://www.sfdaChina.com/info/80-1.htm
2. William J B, Kenneth L, Hastings, Kathy M. Nonclinical Safety Assessment: A Guide to International Pharmaceutical Regulations. McGown John Wiley & Sons; 2013.
3. Wikipedia, the free encyclopedia. [Internet]. 2013 [cited, 2014 Jan] Available from: http://en.wikipedia.org/wiki/Pharmacopoeia of the People's Republic of China.
4. Tiger med news, [Internet]. 2014 [cited, 2014 Jan] Available from:
http://www.tigermed.net/newsinfozz.php?newid=131
5. China CFDA (SFDA) regulations [Internet]. 2014 [cited, 2014 May]. Available from: http://www.sfdaChina.com/.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM
